ArticleKidney international reports2026
Transplantation and Mortality in Women After Delivering on Hemodialysis.
Article in Kidney international reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Trends, underlying-cause structure, and penetration of end-stage kidney disease involvement in U.S. mortality, 1999-2023: a multiple-cause-of-death analysis.Frontiers in public health · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
Introduction: Rates of successful pregnancies among women with end-stage kidney disease (ESKD) on hemodialysis (HD) are increasing, however the risk of preeclampsia and preterm delivery remain high. The association of delivery on HD with subsequent transplantation and mortality are unknown. Methods: Using United States Renal Data System (USRDS) data, females treated with HD who delivered an infant between 2002 and 2019 were identified from ICD-9/10-CM codes and matched up 1:4 by age, vintage, race and ethnicity, and diabetes as primary cause of ESKD, to contemporary females on HD who did not deliver. We assessed transplantation and mortality rates over time after delivery. Cox proportional hazards models were fit to compare transplant and mortality rates between delivering and nondelivering women. All models were adjusted for age, vintage, body mass index (BMI), race, Hispanic ethnicity, incident comorbidities, rural-urbanicity, nephrology care pre-ESKD, Medicare insurance, and prior transplant history; patient waitlist status and panel reactive antibody (PRA) values were also adjusted in the transplant models. Results: One thousand one hundred nine delivering females were matched to 4404 nondelivering females. Unadjusted transplantation and mortality rates for delivering versus nondelivering females were 6.0 versus. 8.6 and 4.5 versus 7.2 per 100 patient-years, respectively. In adjusted models, the hazard ratios (HRs) (95% confidence interval [CI]) for transplant and mortality were 0.78 (0.69-0.88, Conclusion: Although pregnancy on HD has immediate risks of maternal morbidity, infant delivery was associated with a lower risk of long-term maternal mortality. Residual confounding may explain superior survival of delivering versus nondelivering females; however, persistently lower transplant rates in delivering females warrant further research.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.